Skip to Content

Emtricitabine

In the US, Emtricitabine (emtricitabine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF09

CAS registry number (Chemical Abstracts Service)

0143491-57-0

Chemical Formula

C8-H10-F-N3-O3-S

Molecular Weight

247

Therapeutic Categories

Antiviral agent

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of HIV infection

Antiviral agent: Treatment of hepatitis B

Chemical Names

(2R-cis)-4-Amino-5-fluoro-1-[2-(hydroxymetyl)-1, 3-oxatiolan-5-yl]-2(1H)-pyrimidinone (USAN)

2'-Deoxy-5-fluoro-3'-tiacytidine

4-Amino-5--fluor-1-[(2R, 5S)-2-(hydroxymetyl)-1, 3-oxatiolan-5-yl]pyrimidin-2(1H)-on (IUPAC)

5-fluoro-1-[(2R, 5S)-2-(hydroxymetyl)-1, 3-oxatiolan-5-yl]cytosine (WHO)

Foreign Names

  • Emtricitabinum (Latin)
  • Emtricitabin (German)
  • Emtricitabine (French)
  • Emtricitabina (Spanish)

Generic Names

  • Emtricitabine (OS: USAN, JAN, BAN)
  • (-)-FTC (IS)
  • 2-FTC (IS)
  • 524W91 (IS)
  • BW 1592 (IS)
  • BW 524W91 (IS)
  • dOTFC (IS)
  • DRG-0208 (IS)
  • FTC,(-)- (IS)

Brand Names

  • Adco-Emtevir (Emtricitabine and Tenofovir)
    Al Pharm, South Africa
  • Atripla (Emtricitabine and Efavirenz, + Tenofovir)
    Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Iceland; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, United States; Bristol-Myers Squibb and Gilead Sciences, Austria; Gador, Chile; Gilead, Australia; Gilead, Belgium; Gilead, Canada; Gilead, Switzerland; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, Ireland; Gilead, Macedonia; Gilead, Norway; Gilead, New Zealand; Gilead, Sweden; Gilead, Thailand; Gilead, United States; Gilead Sciences, United Kingdom; Gilead Sciences, Hong Kong; Gilead Sciences International Ltd, Israel; Haemato Pharm, Austria; MSD, Guatemala; MSD, Honduras; MSD, Nicaragua; MSD, Panama; MSD, South Africa; Stendhal, Mexico
  • ATRIPLA (Emtricitabine and Efavirenz, + Tenofovir)
    Bristol-Myers Squibb, Germany; Gilead, Germany
  • Atroiza (Emtricitabine and Tenofovir, Efavirenz)
    Mylan, South Africa
  • Citenvir (Emtricitabine and Efavirenz, Tenofovir)
    Novagen, South Africa
  • Complera (Emtricitabine and Rilpivirine, + Tenofovir)
    Gilead, Canada; Gilead, United States
  • Didivir (Emtricitabine and Tenofovir)
    Cipla Medpro, South Africa
  • Emtricitabine Stada
    Stada-VN JV, Vietnam
  • Emtriva
    Gador, Argentina; Gilead, Australia; Gilead, Belgium; Gilead, Switzerland; Gilead, Czech Republic; Gilead, Germany; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, Greece; Gilead, Ireland; Gilead, Iceland; Gilead, Lithuania; Gilead, Norway; Gilead, New Zealand; Gilead, Poland; Gilead, Romania; Gilead, Sweden; Gilead, United States; Gilead Sciences, United Kingdom; Gilead Sciences, Italy; Gilead Sciences International, Austria; Japan Tobacco, Japan; Stendhal, Mexico
  • Eviplera (Emtricitabine and Rilpivirine, + Tenofovir)
    Gilead, Australia; Gilead, Belgium; Gilead, Switzerland; Gilead, Germany; Gilead, Denmark; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, Ireland; Gilead, Iceland; Gilead, Norway; Gilead, Poland; Gilead, Sweden; Gilead, Slovenia; Gilead, Slovakia; Gilead Sciences, United Kingdom; Gilead Sciences, Italy; Gilead Sciences International, Austria; Haemato Pharm, Austria; Medicopharmacia, Croatia (Hrvatska)
  • Genvoya (Emtricitabine and Tenofovir, + Elvitegravir, + Cobicistat)
    Gilead, Germany; Gilead, United States; Gilead Sciences, United Kingdom
  • Hui Er Ding
    Hebei Yuanzheng Pharmaceutical, China
  • Odefsey (Emtricitabine and Rilpivirine, + Tenofovir)
    Gilead, United States
  • Oditec (Emtricitabine and Tenofovir, + Efavirenz)
    Zifam India, Myanmar
  • Ricovir-EM (Emtricitabine and Tenofovir)
    Mylan, India; Mylan, Thailand
  • Stribild (Emtricitabine and Elvitegravir, + Cobicistat, + Tenofovir)
    Gador, Chile; Gilead, Spain; Gilead, Finland; Gilead, Ireland; Gilead, Norway; Gilead, Sweden; Gilead, United States; Gilead Sciences, United Kingdom; Gilead Sciences, Hong Kong; Gilead Sciences, Italy; Gilead Sciences International, Austria; Japan Tobacco, Japan
  • Teevir (Emtricitabine and Tenofovir, + Efavirenz)
    Mylan, India; Mylan, Thailand
  • Tencitab (Emtricitabine and Tenofovir)
    Pharmacare, South Africa
  • Tenemine (Emtricitabine and Tenofovir)
    Mylan, South Africa
  • Teno-Em (Emtricitabine and Tenofovir)
    GPO, Thailand
  • Tenof-EM (Emtricitabine and Tenofovir)
    Hetero, India
  • Trustiva (Emtricitabine and Tenofovir, + Efavirenz)
    Hetero, India
  • Truvada (Emtricitabine and Tenofovir)
    Aspen Pharmacare, South Africa; Gador, Argentina; Gador, Chile; Gilead, Australia; Gilead, Bosnia & Herzegowina; Gilead, Belgium; Gilead, Canada; Gilead, Switzerland; Gilead, Czech Republic; Gilead, Germany; Gilead, Denmark; Gilead, Egypt; Gilead, Spain; Gilead, Finland; Gilead, France; Gilead, Greece; Gilead, Ireland; Gilead, Iceland; Gilead, Lithuania; Gilead, Latvia; Gilead, Netherlands; Gilead, Norway; Gilead, New Zealand; Gilead, Poland; Gilead, Portugal; Gilead, Serbia; Gilead, Sweden; Gilead, Slovakia; Gilead, Thailand; Gilead, Turkey; Gilead, United States; Gilead Sciences, United Kingdom; Gilead Sciences, Hong Kong; Gilead Sciences, Italy; Gilead Sciences International, Austria; Gilead Sciences International Ltd, Israel; Gilead Sciences Singapore, Singapore; Haemato Pharm, Austria; Inopha, Austria; ipsana pharma, Austria; Japan Tobacco, Japan; Medicopharmacia, Croatia (Hrvatska); Nycomed, Georgia; Stendhal, Mexico; Yuhan, South Korea
  • Viraday (Emtricitabine and Tenofovir, + Efavirenz)
    Cipla, India
  • Vonavir (Emtricitabine and Tenofovir, + Efavirenz)
    Emcure, India
  • Xin Luo Shu
    Baili Pharmaceutical, China

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide